Share: Facebook Twitter LinkedIn
Activity Provided By:

CEimpact

Chronic Kidney Disease. Done Right.

Access Activity

Overview / Abstract:

Renin-aldosterone system inhibitors are the mainstay of therapy for preventing and slowing the progression of chronic kidney disease. Novel therapies have been investigated for their ability to further limit disease progression. Join us to learn if allopurinol is a worthwhile add-on therapy for chronic kidney disease.

Expiration

Feb 10, 2024

Discipline(s)

Pharmacy CPE

Format

Online, Webinar / Webcast / Video

Cost

$9.00

Credits / Hours

0.10

Accreditation

ACPE

Presenters / Authors / Faculty

Joseph Berendse
Assistant Professor
South Dakota State University

Keywords / Search Terms

CEimpact CEimpact CEI Impact CEI ce, chronic kidney disease, journal club, xanthine oxidase inhibitors, live journal club, february journal club, feb journal club

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map